Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Aditya Puri former MD of HDFC bank joins Solara board as chairman
It is designed to tackle mental health issues
This deal makes Meddo, one of the largest health-tech players in India
Drug formulations and biologics make impressive gains
Subscribe To Our Newsletter & Stay Updated
